Veeva Summit: Leaders Share Strategies for Advancing Biopharma Industry

Leaders in the life sciences industry, including Alnylam Pharmaceuticals, BeOne Medicines, Intercept Pharmaceuticals, Merck, Pfizer, and Sanofi, will share strategies for advancing clinical, regulatory, safety, and quality at Veeva's upcoming R&D and Quality Summit. Veeva will showcase innovations, including Veeva AI, which is built into the Vault Platform with direct and secure access to Vault data, documents, and workflows. More than 100 summit sessions will showcase the latest advances and inspire new thinking in areas such as trial oversight, collaboration, and data management.

Leaders in the life sciences industry, including Alnylam Pharmaceuticals, BeOne Medicines, Intercept Pharmaceuticals, Merck, Pfizer, and Sanofi, will share strategies for advancing clinical, regulatory, safety, and quality at Veeva's upcoming R&D and Quality Summit. The event, scheduled for September 3-4 in Boston, will feature insights from these companies on how they are leveraging innovative technologies to enhance various aspects of drug development and manufacturing.

Veeva Systems, a global leader in cloud software for the life sciences industry, will showcase its latest innovations, including Veeva AI. This AI technology is built into the Vault Platform, providing direct and secure access to Vault data, documents, and workflows. The summit will highlight how Veeva AI can be used to create custom agents, furthering the capabilities of Veeva applications.

The summit will feature more than 100 sessions, offering attendees a comprehensive overview of the latest advancements in life sciences. Topics include accelerating development and manufacturing by connecting systems and processes, streamlining clinical operations and data management, and improving trial oversight and collaboration among sites, sponsors, and CROs.

Merck, for instance, is streamlining clinical operations by unifying operations and data management, while FUJIFILM Biotechnologies is moving from a site-based approach to a global quality management system to drive consistency. BeOne Medicine is modernizing regulatory processes to increase efficiency and strengthen compliance, and Immunovant is improving study oversight in outsourced trials with real-time access to CRO data.

Sanofi is streamlining study training with a single, inspection-ready solution, eliminating disconnected systems across study teams and site staff. Memorial Sloan Kettering Cancer Center (MSK) is enhancing engagement with sponsors and CROs, sharing a site perspective.

"Leaders come to Veeva R&D and Quality Summit eager to share their experiences knowing that new ideas can be the difference in getting needed medicines to patients faster. This openness helps the entire community to learn from each other and move the industry forward," said Jim Reilly, president of Veeva Development Cloud.

The event is open exclusively to life sciences professionals and will feature more than 2,000 attendees. For more information, visit [veeva.com/Summit](https://www.veeva.com/Summit).

References:
[1] https://markets.ft.com/data/announce/detail?dockey=600-202508210703PR_NEWS_USPRX____SF56064-1
[2] https://www.prnewswire.com/news-releases/leaders-come-together-to-advance-the-industry-at-veeva-summit-302535201.html